MARSHALL WACE, LLP - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$320,000
-79.9%
68,493
-63.5%
0.00%
-85.7%
Q3 2021$1,595,000
+224.8%
187,433
+743.9%
0.01%
+250.0%
Q1 2021$491,000
-22.6%
22,211
+8.3%
0.00%
-33.3%
Q4 2020$634,00020,5040.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders